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As one part of the cellular response to DNA damage, an error prone polymerase
(DNA polymerase V, composed of an UmuD'2-UmuC protein complex), conducts
SOS mutagenesis in Escherichia coli. However, the protein UmuD present in

Acinetobacter baylyi strain ADP! (UmuDAb) contains an extra N-terminal region.
Furthermore, observations made in our lab have shown that ADPl does not respond
to DNA damage by SOS mutagenesis because of the absence of umuC gene.
UmuDAb upregulates the transcription of ddrR (a DNA damage-responsive gene) in
ADPl. We are thus investigating the function of this UmuDAb in the DNA damage
response. Since UmuD of E. coli self-cleaves around 20 minutes after DNA damage
to carry out SOS mutagenesis, and UmuDAb disappears -20 minutes after mitomycin
C (a DNA damaging agent) treatment, we hypothesize that UmuDAb also selfcleaves in response to DNA damage. We have created a mutation in the predicted
cleavage site ofUmuDAb. The mutated umuDAb gene was cloned into an expression
vector and transformed into wild type, umuD, and recA strains of E. coli.
Surprisingly, immunoblot analyses have shown that UmuDAb, mutated at the

predicted cleavage site of ADP 1, still disappears after mitomycin C treatment when
expressed in E.coli. We have also created a mutation in a Lys-156 residue that, in E.

coli, activates nucleophilic attack mediated by serine at the predicted cleavage site.
Immunoblot analyses have sho~n that UmuDAb that is mutated at the nucleophilic
activator site does not disappear after mitomycin C treatment when expressed in E.

coli. Our observations conclude that lysine residue is essential for the cleavage of the
protein like in E. coli. Moreover, UmuDAb is expressed but does not disappear in
recA strains, which suggests that RecA is required for the self-cleavage of UmuDAb

after DNA damage like in E. coli. We thus speculate that UmuDAb cleaves in
response to DNA damage and we are interested in studying the regulatory function of
the cleaved UmuDAb in response to DNA damage. Future directions will involve
more studies on the predicted cleavage site of ADP! as well as the serine residue that
mediates the cleavage of the protein.
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Introduction

Genomic DNA replication is necessary for the continuity of life, but as
various endogenous or exogenous factors can damage DNA, cells must implement a
variety of DNA damage repair mechanisms in order to sense and repair these
damages. There are two main ways cells can sense and repair damages: error-free and
error-prone repair mechanisms. Error-free repair mechanisms, as the name implies,
repair the DNA damage without creating any mutations while error-prone
mechanisms repair the DNA at the cost of increasing mutation loads in the DNA.
Most research has been performed in Escherichia coli model system. Nevertheless,
different types of organisms, prokaryotes and eukaryotes, have evolved various types
of DNA damage repair systems and mechanisms. The focus of the research is to study
the error-prone repair system, specifically SOS mutagenesis, a type of error-prone
repair mechanism that has been extensively studied in E. coli.
This thesis will discuss different types of DNA damage and DNA damage
repair systems. The SOS response system in E. coli and our developing information
on a similar response system in Acinetobacter baylyi strain ADPl which encompasses
error-free and error-prone repair systems, will be discussed. Mainly, my thesis will
test if there is cleavage in an SOS response protein, UmuDAb, of ADPl after DNA
damage. With the help of mutations that I have created at the predicted cleavage site
and nucleophilic activator site of the protein, this thesis work will primarily test if the
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SOS response protein self-cleaves in response to DNA damage. UmuD of E. coli
self-cleaves around 20 minutes after DNA damage to cany out SOS mutagenesis.
Interestingly, UmuDAb also disappears ~20 minutes after mitomycin C (a DNA
damaging agent) treatment, and we hypothesize that UmuDAb also self-cleaves in
response to DNA damage.
DNA damage
Sources ofDNA damage

Sources of DNA damage can be either endogenous (within the cells) or
exogenous (sources outside of the cells). Many naturally found factors as well as
man-made artificial agents can induce DNA damage (Ames, 1979). Endogenous
sources of DNA damage include errors that occur during DNA replication when
proofreading function of DNA polymerases have failed to fix them. The cellular
environment itself is thus a continuous source of DNA damage (Cassimeris et al.,
2010). A wide variety of chemical agents can alter specific bases within nNA. For
example, reactive oxygen species such as hydroxyl radicals react with guanine to
form 8-oxoguanine. 8-oxoguanine pairs with adenine instead of cytosine during DNA
replication, which results in spontaneous transversion DNA mutations (Snyder et al.,
2007; Tropp, 2008). Deamination is another process that causes DNA mutation. For
example, nitrous acid (HN0 2) can cause deamination by converting adenine to
hypoxanthine, which can then base pair with cytosine rather than thymine to cause
DNA mutation (Berge et al., 2007).
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Nucleotide bases are also subject to alkylation in addition to oxidation and
deamination. Alkylating agents include mitomycin C (MMC), aflatoxin B1, nitrogen
mustard gas (bis[2-chloroethyl]methylamine) and ethylmethane sulfonate (EMS).
MMC (See Figure 1 for structure) is a potent DNA crosslinker and crosslinking by
MMC is specific for the duplex DNA sequence CpG•CpG (Tomasz, 1995). The 2NH2 group of the strand opposite to guanine is required for selective monoalkylation.
The 2-NH2 group can form a hydrogen bond with the Cl0' oxygen of the activated
MMC, and this non-covalent bond increases the rate of formation of the covalent
bond with the target guanine (Tomasz, 1995) (Figure 2). Thus, the double helix
structure of DNA can be distorted and results in replication arrest and cell death if the
crosslink is not repaired. Other compounds such as psoralens produced by the
Chinese herb, Psoralea corylifolia can form inter-strand cross-links, which also
prevent replication and gene expression because the cross-linked strands cannot be
separated (Berg et al., 2007).
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Figure I. Mitomycin C Structure

Figure 2. DNA crosslink caused by MMC

(Adapted from Webb et al., 1962)

(Adapted from Tomasz, 1995)

Base analogs resemble the normal bases in DNA and are sometimes
converted into a deoxynucleotide triphosphate and become incorporated into DNA.
The incorporation of a base analog such as 2'-aminopurine (2-AP), and 5'bromouracil (5-BU) can be mutagenic, as the base analog pairs with the wrong base.
2-AP resembles adenine and pairs with thymine, while 5-BU is an analog of thymine
and wrongly base pairs with adenine (Snyder et al., 2007).
One of the major exogenous sources of DNA damage is radiation. Radiation
can be subdivided into two types: UV radiation and ionizing radiation (X-rays and
gamma rays). The ultraviolet (UV) component of sunlight is a DNA-damaging agent
(Cassimeris et al., 2010). UV light functions by covalently linking adjacent
pyrimidine residues (thymine-dimers) along a DNA strand. The intrastrand cross-
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linking causes a distortion of the double helix structure of DNA as pyrimidine dimers
can fit into a double helix and completely block replication and gene expression
(Berg et al., 2007). X-rays and gamma-rays cause a variety of DNA lesions and these
lesions can be a result of direct damage to the DNA or indirect damage when the
radiation produces reactive species such as reactive oxygen species (ROS) in the
cells. Ionizing radiation is lethal to the cells and a double-strand break is the most
common DNA damage caused by ionizing radiation (Cassimeris et al., 2010).
Types of DNA damage

Exposure of DNA to endogenous or exogenous DNA damaging sources
causes mutations in DNA. The mutations result from changes in DNA sequence or
deletions, insertions or rearrangement of DNA sequence. A base substitution is the
simplest type of mutation, where a nucleotide pair in a DNA is replaced with a
different nucleotide. Some base substitutions replace a pyrimidine base with another
pyrimidine or one purine base with another purine base; these are called transition
mutations. On the other hand, while a pyrimidine base is replaced with purine base or
one purine base is replaced with pyrimidine base, the substitution is referred to as
transversion mutations. The mutations in DNA sequence as a result of these base
substitutions can change an amino acid sequence, truncate the protein, or shift the
reading frame.
A missense mutation or non-synpnymous mutation changes results in one
amino acid being replaced with another and this replacement in a protein alters the
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biological property of the protein. Diseases such as phenylketonuria and sickle-cell
anemia are caused by missense mutations. A nonsense mutation is a base substitution
that creates a new stop codon, making a polypeptide truncated. The premature chain
termination renders the polypeptide non-functional. A silent or synonymous
substitution changes the nucleotide sequence without changing the amino acid
sequence. A silent substitution is so called because it is not detectable by changes in
phenotype. In addition, a frameshift mutation caused by addition or deletion of a
single base shifts the reading frames of the codons in mRNA. A frameshift mutation
results in synthesis of nonfunctional protein as the frameshift alters the amino acids
downstream from the site of mutation (Hartl et al., 2002). DNA damaging agents
used in this study are UV radiation, which induces frameshift mutation in bacteria
(Hartman et al., 1971; and Miller, 1985) and mitomycin C (MMC), which induces
either a base substitution or a frameshift mutation (Minear et al., 1995).

DNA damage a11d repair systems
When a cell's DNA is damaged, the cell senses and respond to the DNA
damage with activation of an error-free repair system or error-prone repair system
(Figure 3). Most of the SOS genes are induced rapidly after DNA damage and are
involved in an error-free DNA repair, such as base excision repair (BER), nucleotide
excision repair (NER), and recombinational DNA repair (Friedberg et al., 2006).
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Figure 3. DNA damage repair mechanism in prokaryotes.

However, if the levels of DNA damage are tremendous, then error-free repair systems
cannot repair the damage and the replication is halted. Now, the mutagenic phase of
SOS response is triggered (Walker, 1984; Echols and Goodman, 1990). After sensing
DNA damage, a cell's repair machinery attempts to fix the DNA damage and it may
lead to the following scenarios: 1) the DNA is repaired perfectly, also known as errorfree DNA repair; 2) the damage cannot be repaired or the repair is incomplete and the
cell undergoes apoptosis; and 3) the cell carries out error-prone repair with increased
levels of mutations in DNA.

Error-free DNA repair
Most of the repair pathways can sense the initial DNA lesion and function by
removing the lesion (either a single base or larger area in the damaged region). The
repair pathways then use the information on an undamaged complementary strand to
synthesize nucleotides in the damaged area and thus restore the information content
oftheDNA.
In some cases, however, DNA damage can be simply reversed through the
action of an enzyme such as photolyase. The system is called a direct repair system or
photoreactivation repair system (Schul et al., 2002). The photoreactivation is so
called because this type of repair occurs only in the presence of visible light. The
photolyase enzyme uses the energy of an absorbed photon to directly bind to a cyclic
pyrimidine dimer (CPD), which is the damaged area, and cleaves the cyclobutane
ring, restoring the original normal structure of the pyrimidine monomers (Yasui et al.,
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1994). The damaged DNA can also be directly repaired in a second type of direct
repair by the action of a group of enzymes known as alkyltransferases (Pegg and
Byers, 1992). A wide variety of these enzymes with specificities for different types of
lesions have been reported in prokaryotes (Cassimeris et al., 2010). One of the
alkyltransferase enzymes, DNA glycosylase, can remove a variety of alkylated
substrates. Alykltransferases restore the original structure of a base by transferring the
alky group from a damaged base to themselves (Krokan ei al., 1997). The irreversible
attachment of the alkyl groups makes these enzymes inactive, therefore these
alkyltransferases are also known as "suicide enzymes" (Cassimeris et al., 2010).
Sometimes wrong nucleotides are mistakenly inserted by DNA polymerase III
into the newly synthesized strand of DNA during DNA replication. The incorrectly
inserted nucleotides are then usually removed by an enzymatic DNA repair process
known as DNA proofreading. DNA polymerase I acts as nuclease and recognizes and
removes mismatched bases by hydrolysis at the 5' end of the mismatched nucleotide.
Since DNA polymerase I has a 3'-5' exonuclease activity, the removal of a nucleotide
at the 5' end results in a free 3' OH group in the preceding base; this allows for the
insertion of a correct nucleotide (Liu, 2007).
Another type of DNA damage repair mechanism, the excision repair system
can be further sub-divided into three types: base-excision repair (BER), nucleotide
excision repair (NER), and mismatch repair (MMR). BER removes bases damaged by
alkylation, deamination, and oxidation (Cassimeris et al., 2010). Classes of enzymes
known as DNA glycosylases (similar to alkyltransferases) and AP endonucleases are
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the key players in the BER system. DNA glycosylase removes the damaged base
from DNA and attaches it into an active site of the enzyme, and cleaves the Nglycosyl bond of the deoxyribose. The next stage of the pathway is followed by
cleavage of the phosphodiester backbone so that abasic [apurinic/apyrimidinic (AP)]
sites left in the DNA can be removed and replaced. AP endonuclease recognizes the
AP sites and cleaves the DNA backbone 5' to the AP site. As a result, there is a gap in
the DNA with a 5'-deoxyribose phosphate and 3'-OH, which can then be repaired by
DNA polymerase I and DNA ligase (Cassimeris et al., 20 I 0).
On the other hand, the nucleotide excision repair (NER) removes a large -12
base region containing a DNA lesion. The resulting gap is the filled in with
nucleotides using the intact DNA strand as a template for DNA polymerase. A wide
range of DNA lesions such as thymine dimers resulting from UV irradiation,
aflatoxin-damaged bases, and DNA cross-links can be repaired by the NER pathway.
A mutation in human nucleotide excision repair (NER) genes can cause a disease
called xeroderma pigmentosum (XP), which leads to an 1,000 fold increase in the
incidence of skin cancer (Cassimeris et al., 2010).
The mismatch repair is a type of excision repair, which recognizes and repairs
the DNA containing the mismatch by its replacement with the correct sequence using
the complementary strand as a template. The major genes involved in MMR are

mutH, mutL, and mutS (Cox, 1997). The MutH protein first binds to a mismatch and
the MutL protein is recruited. The MutH-MutL complex then activates MutH
endonuclease, which nicks the DNA at the nearest unmethylated GATC site (Iyer et
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al., 2006). The nick acts as an entry point for helicase II to unwind the DNA
containing the mismatch. Exonucleases degrade the unwound DNA containing the
mismatch and DNA polymerase III fills in the resulting gap using the intact DNA
strand as a template (Duckett et al., 1996).
Error-pro11e DNA repair
When error-free mechanisms cannot repair DNA damage, then error-prone
repair systems come into play. The "SOS response" was first described and coined by
Miroslav Randman in 1974 (Radman, 1974). The SOS response comprises over 20
unlinked genes such as recA, lexA, umuDC, polB, recN, sulA, uvrA, uvrB, and uvrD
(Friedberg et al., 1995) and are induced after a cell is exposed to a DNA-damaging
agent such as UV irradiation or chemicals (Witkin, 1976; Walker, 1984). Most of the
SOS genes are induced rapidly after DNA damage and are involved in error-free
DNA repair, such as base excision repair (BER), nucleotide excision repair (NER),
and recombinational DNA repair (Friedberg et al., 2006). The SOS response is an
inducible system and encompasses error-free and error-prone functions. The errorprone SOS response is responsible for mutagenic events that occur when DNA
damage cannot be repaired in an error-free manner (Walker, 1984; Echols and
Goodman, 1990) and thus is called SOS mutagenesis.
When cells experience lethal DNA damage and error-free mechanisms cannot
repair the damage but cells are under pressure to replicate, an alternate umuDCdependent process that leads to translesion synthesis (TLS) is induced (Bridges and
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Woodgate, 1985; Sutton et al., 2000; Goodman, 2002). TLS repairs UV-induced
DNA damages and induces errors in the general vicinity of lesions. The error-prone
response system is usually the last inducible system in effect in response to DNA
damage when error-free repair systems cannot cope with the damage (Lodish et al.,
2000). The umuC and umuD genes that act on SOS mutagenesis are turned on -30
min after the cells have been exposed to UV (Sommer et al., 1998)
These mechanisms of DNA repair such as error-free and error-prone repair
mechanisms are also found in eukaryotes (Hubscher et al., 2002; Gan et al., 2008).
Mutations in any of these DNA-damage repair pathways may lead to cancer in
humans.
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The SOS mutageuesis system
SOS mutage11esis i11 E. coli

The DNA damage in E. coli by agents such as UV light, mitomycin C, or
fungal metabolites like aflatoxin BI generates a signal that activates RecA protein to a
form (RecA *) that can promote the proteolytic self-cleavage of the LexA repressor
(Horii et al., 1981). The result of the inactivation of LexA repressor by proteolytic
cleavage is the increased expression of SOS genes such as umuD, umuC, recA (Little
et al., 1982; Walker et at:, 1984) and many other SOS response genes such as polB,
recN, sulA, uvrB, and uvrD (Friedberg et al., 1995). LexA is a repressor protein that
negatively regulates the transcription of the SOS genes and other genes by binding to
a 20 nucleotide "SOS box" (Lewis et al., 1992) in the promoters of these genes and
interferes with the RNA polymerase transcription of the SOS response genes (Mount
et al., 1972, and Brent et al., 1981). With the extensive amount of research done on E.
coli 's SOS mutagenesis response, we know that Umu proteins play a causal role in
damage-induced mutagenesis in E. coli (Steinborn, 1978; Kato et al., 1977). E. coli
umu genes are found in an umuDC operon. The umuD gene is smaller in size and
overlaps umuC gene by one base pair (Gonzalez et al., 2002). The umuD and umuC
genes encode for proteins of 15.0 and 47.7 kDa, respectively (Kitagawa et al., 1985).
RecA * also facilitates the cleavage of UmuD to its shortened form UmuD'. UmuD
and UmuD' can bind to each other to form a heterodimer or combine with a copy of
itself, forming a homodimer. The resultant heterodimer or homodimer can combine
with UmuC, forming a variety of different complexes, including the error-prone DNA

13

polymerase V that carries out SOS mutagenesis. The Umu(D) 2C complex participates
in regulating the E. coli cell division cycle after DNA damage by slowing down the
cell cycle and allowing more time for error-free repair mechanisms to act (Opperman

et al., 1999). The UmuDD'C seems to be an inactive form and may play a role in
shutting off SOS mutagenesis by binding with the UmuD'. The (UmuD')2C complex
(the error-prone DNA polymerase V) (Figure 4) causes SOS mutagenesis (Tang et al.,
1999). Thus, the SOS mutagenesis system requires umuD+c+ and recA+ and allows
the cells to replicate through unrepaired lesions in the template DNA that cannot be
repaired in an error-free manner (Tang et al., 1999). The survival rate of the cells is
increased while mutation rate is elevated as a result of the translesion synthesis
(Friedberg et al., 1995; Sutton et al., 2000).
There are two DNA polymerases that carry out SOS mutagenesis: DNA pol
IV and DNA pol V. DNA pol IV was first discovered in 1999 and reported to be
encoded by the SOS gene dinB (Wagner et al., 1999). DNA pol IV lacks intrinsic 3'5' exonuclease proofreading activity (Tang et al., 2000; Goodman, 2002). The fidelity
of the DNA pol IV is achieved by its ability to differentiate between correct and
incorrect base formation. In a normal cell, the level of DNA pol IV is approximately
250 molecules per cell and this can increase up to IO-fold upon DNA damage (Kim et

al., 2001)
DNA pol V is a Y-family polymerase and is a major translesion synthesis
(TLS) polymerase in E. coli (Goodman, 2002). Although DNA pol IV (dinB) is
induced rapidly after DNA damage (Qiu et al., 1997 and Kim et al., 2001), DNA pol
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V (UmuD'2C) is not detectable until 20-40 min post SOS induction (Sommer et al.,
1998). The delayed expression is useful to the bacterium because it provides an

opportunity for the cell to repair the damaged DNA before the cells undergo
mutagenic translesion synthesis (Pham et al., 2002).
DNA pol V was also first identified in 1999 (Tang et al., 1999, and Reuven, et
al., 1999) and is encoded by the umuDC locus. DNA pol V consists of a dimer of

post-translationally cleaved UmuD' protein complexed with a monomer of UmuC
(Woodgate, et al., 1989). The amount of DNA pol Vin a normal cell is 15 molecules
per cell while it can reach 200 molecules per cell upon DNA damage (Woodgate et
al., 1991). DNA pol V also lacks 3'-5' exonuclease proofreading activity, therefore it

is considered a low fidelity DNA polymerase. DNA pol V is essential for most in
vivo damage-induced SOS mutagenesis in E. coli because of its ability to bypass
lesions when the replication fork is stalled due to lethal DNA damage.
SOS Mutage11esis i11 11011-E. coli models

SOS mutagenesis has also been studied in many different bacteria such as
Bacillus (Love et al., 1984; Love et al., 1986), Mycobacterium (Movahedzadeh et al.,
1997), and Xanthomonas (Yang et al., 2002). Studies have shown that the SOS

mutagenesis systems found in these bacteria are similar, but not identical, to that of E.
coli.

The SOS box and LexA repressor proteins are found to be conserved among
these bacteria. The recA gene has been found in all sequenced eubacterial genomes
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(Campoy et al., 2002). RecA protein possesses the following wide range of functions
in different bacterial species: 1) the homologous DNA pairing and strand exchange
with a homologous duplex of DNA (Lusetti and Cox, 2002), 2) induction of SOS
response (Walker et al., 2000), and 3) interaction with the mutagenic proteins to carry
out translesion synthesis (Bridges and Woodgate, 1985; Goodman, 2002). Proteins
homologous to RecA are found in both archaea and eukaryotes. In archaea, the RecA
homolog is called RadA (Seitz et al., 1998; Yang et al., 2001; Wu et al., 2004), while
two RecA homologs, Rad51 and Dmcl proteins are found in eukaryotes (Bishop et
al., 1992; Shinohara et al., 1992; Sung, 1994). In contrast, the number of lexA genes
present in bacteria is variable, ranging from zero in Helicobacter pylori (Campoy et
al., 2002) to two in Xanthomonas axonopodis pathovar citri (Yang et al., 2005). In
addition, the SOS box sequences are also found to vary between different bacterial
classes, such as TACTG(TA)sCAGTA for E.coli (Walker, 1984), TTAG(N6)TACTA
for Xylellafastidiosa (Campoy et al., 2002), CCAACRNRYGTTCYC for B. subtilis
(Winterling

et

al.,

1998),

and

GGTT(N2)C(N4)G(N3)ACC

for

Geobacter

sulfurreducens (Jara et al., 2003). Interestingly, no sequence similar to known SOS
boxes are found in ADPl (Hare et al., 2006; Rauch et al., 1996).
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Acinetobacter
General microbiology

Acinetobacter are Gram-negative, strictly aerobic, non-fermenting, nonfastidious,

non-motile,

catalase-postitive,

oxidase-negative,

coccobacillary

gammaproteobacteria with a G+C content of 39% to 47% (Rossau et al., 1991).
Members of the Acinetobacter genus are considered ubiquitous organisms in the
environment; they can be abundantly recovered from virtually all samples such as soil
and surface water (Baumann et al., 1968). Members of the Acinetobacter genus have
been historically classified by various researchers under numerous different
taxonomic names such as Bacterium anitratum; Here/lea vaginicola, Mirna
polymorpha;

Achromobacter,

Alcaligenes,

Micrococcus

calcoaceticus,

and

Moraxella glucidolytica and Moraxella lwofjii (Bergogne-Berezin et al., I 996); at
present the genus Acinetobacter is classified in Phylum Proteobacteria, Class
Gammaproteobacteria,

Order

Pseudomnadales,

and

Family Moraxellaceae.

Members of Acinetobacter species are typically non-pathogenic; however pathogenic
strains of A. baumannii (Peleg et al., 2008), A. lwojji (Rathinavelu et al., 2003), A.
ursingii, A. schindlerii (Nemec et al., 2000), and A. baylyi (Chen et al., 2008) have
been reported.
Some of the bacterial species of Acinetobacter, such as A. baumannii are
increasingly becoming a source of hospital-acquired infections (Peleg et al., 2008).
The resistance of A. baumannii to disinfectants and its ability to survive for a
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prolonged period of time in a hospital environment helps the organism in nosocomial
spread (Peleg et al., 2008). The ability of A. baumannii to upregulate or acquire
resistance determinants makes it one of the most important species of clinical
relevance. Strains of A. baumannii have been found to be resistant to most of the
known clinical antibiotics (Peleg et al., 2007), which requires this species to be added
to the list of organisms challenging the modem antibiotic era. A. baumannii are
commonly associated with hospital acquired pneumonia and wound infections but
currently the incidence of infections involving the nervous system, skin and soft
tissue, and bone appears to be increasing (Peleg et al., 2008).

General features of ADPJ for being a good model organism

Acinetobacter baylyi strain ADPI is a ubiquitous soil and aquatic bacterium
and has a capacity for natural transformation during late log phase (Young et al.,
2005). Because Acinetobacter spp. can use a variety of carbon sources, they can be
grown on simple media in lab (Barbe et al., 2004). With an optimal temperature
between 30°C and 37°C, ADP! can even grow slowly in room temperature (Metzgar

et al., 2004). Because of its relatively small genome size of 3. 7 Mbp, which has
recently been sequenced (Barbe et al., 2004), ADPI 's genes can be readily
manipulated in the lab. Moreover, ADPI is a good candidate as an industrial
microorganism because they are harmless to humans as they do not carry any genes
classically associated with pathogenesis or virulence (Barbe et al., 2004). Moreover,
several antibiotics that are commonly used against E. coli are also effective against
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ADP 1, and many antibiotic resistance cassettes used in E. coli can also be transferred
in ADPl with ease (Kok et al., 1995). Additionally, ADPl 's property of natural
competence (Young et al., 2005) and a natural tendency toward homology-directed
recombination (de Vries et al., 2002) makes it a comparatively superior candidate
over E. coli for research involving genetic manipulation. ADPl in their exponential
growth phase are approximately 10-100 times as competent as calcium chloride
treated competent E. coli (Metzgar et al., 2004). All of these characteristic features of
ADPl point to the fact that ADPl is an excellent bacterial model and surpasses the
expectations of E. coli. Furthermore, as a non-enteric gammmaproteobacteria, ADPl
is an excellent model to examine basic cellular processes other than E. coli.
DNA damage response in Aci11etobacter
Acinetobacter sltares features witlt E. coli i11 respo11se to DNA damage

After DNA damage, at least two DNA damaging response genes are induced
in ADPl: ddrR (DNA damage-responsive gene) and recA (Hare et al., 2006; Rauch et

al., 1996). In its response to DNA damage, ddrR requires RecA for induction
(Whitworth et al., 2000). However, ADPl shows some unique.features in response to
DNA damage. ADPl does not respond to DNA damage with SOS mutagenesis
(Berenstein, 1987). The recA gene is induced by DNA damage in ADPl as in E.coli,
but unlike in E. coli, the induction of recA does not require the RecA protein (Rauch

et al., 1996). Moreover, several E. coli DNA damage proteins such as DinB, cr38 ,
SulA, FtsEX, and LexA are not found in Acinetobacter spp. (Robinson et al., 2010).
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A. baylyi strain ADPl MutS protein has been shown to recognize mismatches

that arise during DNA replication and homologous recombination similar to E. coli
(Young et al., 2001 ). The MutS protein preferentially recognizes transition
mismatches and 1-bp frameshifts. However, the protein does not recognize neither
transversion mismatches nor large insertions or deletions (Young et al., 2001 ).
Absence of LexA and SOS box

The ADPl recA and ddrR promoters lack a known SOS box (Gregg-Jolly et
al., 1994; Hare et al., 2006). ddrR is encoded next to the 'extra-long' UmuDAb in

many Acinetobacter species, especially in A. baumannii (Personal communication
with J. Bradley and J. Hare). Furthermore, there is absence of a LexA homolog in
APDl. This means that umuDC operon in ADPl is constitutively expressed and is not
regulated by DNA damage or recA (Hare et al., 2006).
ADP] and other bacteria have "extra-long" UmuD

The umuDAb gene found in A. baylyi has an extra N-terminus region unlike E.
coli and other bacteria. The umuDAb gene of ADPl is 612 bp long and encodes·a

gene product of 203 amino acids, while the umuD gene found in E. coli and other
bacteria encodes 140 amino acids (Figure 5). The umuD found in ADP 1 is thus about
1.5 times the size of umuD in E. coli and other bacteria (Hare et al., 2006). This
means that umuDAb gene of ADPl has a capacity to encode a larger protein and this
larger size may be what carries out a different regulatory response to DNA damage

21

than umuD of E. coli. Research has shown that the functioning of the umuDAb
encoded gene product is unlike other bacteria such as E. coli (Hare et al., 2006).
Other bacteria such as Synechococcus elongatus, Legionella pneumophila
strain Lens, and Chromobacterium violaceum have "extra-long" UmuD similar to
ADP! (Figure 8). The function of these "extra-long" UmuD homologs have not been
studied in these bacteria but their sequence was identified in the sequenced genomes
(Hare et al., 2006).
umuC ofADP] is mutated

The umuC gene of ADP! is interrupted and incomplete, and there is also an
insertion sequence fragment in between the interrupted umuC gene fragments (Figure
5; Hare et al., 2006). The umuC fragments together contain 43% of the length of E.
coli umuC gene (Hare et al., 2006). The 348-bp fragment of umuC is positioned 5.9
kbp downstream of umuDC, which encodes 114 amino acids of UmuC with 28%
identity to UmuC (Hare et al., 2006). The mutated umuC gene encodes 39 amino
acids with 85% identity to the amino-terminal end ofUmuC. The umuC fragments are
interrupted by a putative transposase gene, which is 72 bp long and is homologous to
ISEhe3, and is found in the opposite orientation (Hare et al., 2006). Moreover, ADP!
does not respond to DNA damage by SOS mutagenesis (Hare lab, data not shown),
which correlates with the fact that ADP! has a mutated umuC. This feature of ADP!
is unusual when compared to E. coli model system. Thus, experiments performed in
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ADPl and its DNA damage response system might give us new insights into how
UmuDAb

acts,

aside

from

its

action
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Figure 5. Differences in AD Pl from E. coli model. The umuDAb is 1.5 fold longer than umuD. The umuC gene of ADPI

is interrupted and incomplete, and there is also a presence of insertion sequence fragment in between the interrupted umuC
gene. A genetic locus, ddrR is present in ADPI, which has no homologs in E. coli or any other bacteria. This figure is
adapted from Hare et al., 2006.

SOS proteins UmuD and LexA belong to a serine-protease family that selfcleaves
UmuD and LexA both belong to a serine-protease family that uses a serine('

lysine catalytic dyad mechanism that helps in the self-cleavage of the protein (Paetzel
et al., 1997). The Ser-119 and Lys-156 residues ofLexA are key residues needed for

this cleavage (Little, 1991 ). First, the Ser-119 acts as a nucleophile and attacks the
peptide bond in the cleavage site. Second, the uncharged Lys-156 acts as an activator
by helping a proton to leave the serine hydroxyl group by donating a proton to the
leaving amino group. Activated RecA (RecA*) facilitates this cleavage of LexA by
lowering the pK. of the Lys-156 residue and thus indirectly helps in the cleavage of
LexA (Figure 7). The peptide bond is now cleaved and a covalent ester intermediate
is formed (Little, 1991 ).
The percent identity between MucA, a UmuD homolog and the putative UV
protection protein of Salmonella enteria serovar Typhi (Horii et al., 1981) and LexA
is -28%, while UmuD is 31 % homologous to amino acids in the COOR-terminal
domain of LexA (Perry et al., 1985) (Figure 6). E. coli UmuD is 140 amino acids and
shares carboxyl-terminal homology with LexA (Walker, 1996). The sequence
homology between UmuD and LexA suggests that RecA * interacts with UmuD
(Perry et al., 1985). Firstly, RecA * initiates the proteolytic cleavage of LexA.
Secondly, the interaction of RecA * with UmuD results in the post-translation
cleavage of UmuD, which precedes in a similar fashion as that of LexA repressor.
RecA * is also thought to play a role in helping UmuD dire.ct to its site of action
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(Perry et al., 1985). The post-translation cleavage of UmuD is essential as only the
dimer of UmuD' complexes with UmuC to form DNA pol V to carry out SOS
mutagenesis.
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Figure 6. Homology of UmuD aud MucA proteins to the LexA protein. Underlined amino acids indicate the identities
between the LexA repressor and either the UmuD or MucA proteins. The Ala-Gly cleavage site of LexA is between amino
acids 112 and I 13 while the Cys-Gly putative cleavage site of UmuD is between amino acids 24 and 25. Adapted from
Perry et al., 1985.
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Does UmuDAb self cleave after DNA damage?

Studies have showu as mentioned above, that after DNA damage UmuD gets
expressed in E. coli, and then self-cleaves post-translationally to form truncated
UmuD'. A dimer ofUmuD' can then combine with UmuC protein to form DNA pol
V, which can then carry out SOS mutagenesis. Similarly, in ADP!, at least two DNA
damaging response genes are induced in ADP!: ddrR (DNA damage-responsive
gene) and recA (Hare et al., 2006). The induction of ddrR is dependent on the
activation of UmuDAb. Therefore, the question we pose is: Does UmuDAb selfcleave to induce ddrR? To understand if UmuDAb indeed regulates ddrR expression
after DNA damage, there is therefore a need to examine whether a self-cleavage of
UmuDAb occurs after DNA damage.
Goals for the thesis

The possible cleavage ofUmuDAb in A. baylyi's response to DNA damage is
poorly understood. However, UmuDAb contributes. to DNA damage response by
regulating ddrR. But we do not know if UmuDAb self-cleaves in response to DNA
damage like E. coli UmuD or if such self-cleavage is required for its regulation of
ddrR. Therefore, as a first step, we are interested in studying whether UmuDAb self

cleaves when induced to DNA damage or how UmuDAb behaves in response to
DNA damage. At the same time, we are also interested in examining the effects of
changing amino acid encoded by umuDAb on the potential cleavage of the gene
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product after inducing the cells to DNA damage. This will tell us if cleavage, if it is
indeed happening, proceeds like in the E. coli model.
The cleavage site of E. coli UmuD is the bond between Cys-24 and Gly-25
(Perry et al., 1985). Nohmi et al (1988) observed that by changing the Gly-25 residue
of the putative Cys-Gly UmuD cleavage site to a glutamic acid or lysine residue
significantly reduced the ability of UmuD to function in SOS mutagenesis. Changing
the Cys-24 to a tyrosine residue caused a less severe reduction in the ability ofUmuD
to functiqn in UV mutagenesis. Moreover, changing either Ser-60 or Lys-97 to an
alanine residue drastically reduced the ability of UmuD to function in UV
mutagenesis. Changing Ser-60 to a cysteine residue resulted in a less severe reduction
in UmuD's ability to function in UV mutagenesis than the Ser-60 to an alanine
residue change (Nohmi et al., 1988).
UmuDAb, the UmuD homolog of A. baylyi has many amino acids that
involved in nucleophilic attack at the Cys 24-Gly25 in E. coli and the lysine-97 that
assists are essential in E. coli for Rec-A facilitated UmuD self-cleavage. Serine-60,
which is in the nucleophilic attack are well conserved in UmuDAb. The putative
cleavage site in UmuDAb is Ala83 -Gly84 (Hare et al., 2006) unlike Cys24-Gly25 in
UmuD of E. coli. However, studies have shown that the cysteine in UmuD when
substituted for alanine, did not affect the biological function of the umuD gene
product (Lee et al., 1994). This observation leads us to an assumption that the UmuD
and UmuDAb behave in an identical way. However, future studies will examine the
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function and regulatory characteristic of the extra N-terrninus ammo acids of
UmuDAb.
Multiple sequence alignment of UmuD and UmuD homologs suggests that
alanine-83/glycine-84 is the cleavage site of UmuDAb since the serine and lysine
residues needed for cleavage are conserved in E. coli UmuD and UmuD homologs in
other bacteria (Figure 8). A helpful way to illustrate if the predicted cleavage site in
UmuDAb is indeed where the protein cleaves would be to create different types of
mutations in either the cleavage site or the residues that are essential for cleavage.
The three goals of my project are to: 1) study expression and cleavage of normal
UmuDAb after DNA damage, 2) mutate alanine in the putative Ala-Gly cleavage site
to glutamic acid and study the expression of the mutated gene product in E. coli wild
type and recA strains by Western analyses, and 3) mutate the lysine to alanine in the
nucleophilic activator residue that helps in the cleavage of UmuD and study the
expression of similar E. coli wild type and recA strains.

In this study, UmuDAb and its mutant versions will be expressed in E. coli
because we understand how SOS mutagenesis occurs in E. coli. E. coli can uptake the
plasmids with the umuDAb gene or any gene of interest easily. It is helpful for us to
study about a protein in an E. coli model system where majority of pathways are
understood rather than in ADP! where less is known about different metabolic and
physiologic pathways. The ease of obtaining different mutant strains of E. coli such
as umuD and recA also make E. coli an excellent model system for us in order to
examine the expression and function ofUmuDAb.
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Figure 8. Multiple alignment of UmuD homologs in different bacterial strains. The serine and lysine residues (second
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Methods and Materials

Bacterial strains

The bacterial strains used in this project are listed in Table 1: Acinetobacter
baylyi strain ADP!, AB! 157 (Escherichia coli K-12 wild type), AB2463 (E. coli
recA13, isogenic to AB1157), 315 (E. coli umuD·, isogenic to AB1157), DH5a (E.
coli recA") and, XL-10 Gold Ultracompetent cells.

All of the bacterial strains examined in this study were grown in nutrient agar
(NA) or Luria-Bertani (LB) broth or tryptic soy broth (TSB). All of the bacterial
strains were grown at 37°C.
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Table 1. Bacterial strains used in this study
Strains

Description

Relevant Characteristic(s)

Source

Reference

ADP!

Acinetobacter
baylyi

Wild type

AB1157

Escherichia coli
K-12

AB2463

E. coli recAl 3
(isogenic to
AB1157)

F-, thr-1, araC14, leuB6(Am), L1(gpt-proA)62,
lacYl, tsx-33, qsr'-0, glnV44(AS), ga/K2(Oc), &
lambda·, Rac-0, hisG4(Oc), ,jbCl, mgl-51,
rpoS396(Am), psL3l(strR), kdgK51, xy/A5,
mtl-1, argE3(Oc), thi-1
0, glnV44(AS), ga/K2(Oc), &lambda·, Rac-0,
hisG4(Oc), ,jbCl,mgl-51, recA13, rpoS396(Am),
rpsL3l(strR), kdgK51, xy/A5, mtl-1, argE3(Oc), thi-1

315

E.coli
umuD:kanR
(isogenic to
AB! 157)

F-, thr-1, araC14, leuB6(Am), L1(gpt-proA)62,
lacYl, tsx-33, qsr'-0, glnV44(AS), ga/K2(Oc), &
lambda·, Rac-0, hisG4(Oc), ,jbCl, mgl-51,
rpoS396(Am), rpsL3l(strR), kdgK51, xy/A5, mtl-1,
argE3(Oc), thi-1, umuD:ka11R

Walker lab Unpublished,
personal
communication with
P. Buening of the
Walker lab

DH5a

E. coli recAl

Invitrogen

XL-10
Gold

E.coli

fhuA2 l':,.(argF-lacZ)Ul69 phoA glnV44
<JJ80 l':,.(lacZ)Ml 5 gyrA96 recAl re/Al endAl thi-1
hsdR17
Te{!':,.(mcrA)l831':,.(mcrCB-hsdSMR-mrr)l73 endAl
supE44 thi-1 recAl gyrA96 re/Al lac Hte [F' proAB
lacl qZl':,.Ml 5 Tnl 0 (Te{) Amy Cam'

GreggJolly lab

Personal
communication with
L. Gre1m-Jolly
Walker lab Dewitt et al., 1962

GreggJolly lab

Stratagene

Howard-Flanders et
al., 1966)

Plasmids used

The plasmids used in this project are listed in Table 2. The pJHI plasmid
contains 2.2 kbp ADP! chromosomal DNA encompassing the umuDC operon and the
ddrR locus cloned into pUC19, which confers ampicillin resistance (Hare et al.,
2006). The pJHI plasmid presumably contains a promoter 5' upstream of umuD.
Construction of plasmids pIX-1 and plX-2 was based upon pJHI.
QIAGEN's EasyXpress Protein Synthesis Kit was used to construct the
plasmids plX-1 and plX-2 that carry the umuDAb gene from pJHI and which were
used in the Kit's two-step PCR process for generating PCR products for in vitro
translation. The first round PCR uses sense and antisense primers that bind to the
umuDAb open reading frame (ORF) and adds extra 'attachment' base pairs for round

2 PCR. In round 2 PCR, the adapter primers provided by the kit that encode an Nterminal histidine tag or affinity tag attach to the 'extra' bp from round I PCR. The
adapter primers add a T7 promoter, ribosomal binding site, and T7 transcription
terminator. The overall two-step PCR process results in PCR products that contain
multiple cloning sites well-suited for cloning into the EasyExpress plX3.0 vector. The
PCR products, once cloned into pIX3.0 (Qiagen), can produce larger amounts of
protein in large scale in vitro reactions. Another benefit of this cloned expression
construct is that the expression construct can be used to transform E. coli cells for
conventional in vivo expression. The pIX-1 and plX-2 plasmids were constructed by
G. Howington and S. Wheeler in 2009. The plX-2 plasmid contains the 612 bp ORF
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of umuDAb plus a ribosomal binding site, and T7 terminator cloned into QIAGEN's
EasyExpress plX3.0 vector and thus encodes a N-terminus histidine-tagged
UmuDAb. The plX-1 plasmid contains the 612 ORF of umuDAb cloned after T7
promoter in the pIX3.0 vector, but encodes no histidine-tag in either the N- or Cterminus ofUmuDAb.
Both plasmids plX-2GtoE and pIX-2KtoA are derived from plX-2. The
plasmid plX-2GtoE constitutively expresses UmuDAb that has a mutation in its
predicted cleavage site

(Gly-84 ➔ Glu).

Similarly, the plasmid plX-2KtoA

constitutively expresses UmuDAb that has a mutation in its nucleophilic activator site
(Lys-156 ➔ Ala).
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Table 2. Plasmids used in this study

Plasmids

Description

Source

pJHl

-2·.2 kbp Acintobacter baylyi strain ADP! chromosomal DNA encompassing the Hare et al., 2006
umuDC operon and ddrR locus cloned into the ampicillin resistant pUC19 cloning
vector

pIX-1

612 bp ofpIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and This study
T7 terminator, no affinity tag

pIX-2

612 bp ofpIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and
T7 terminator, N-terminus histidine-ta!!!!ed

pIX-2GtoE

612 bp ofpIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and This study
T7 terminator with predicted cleavage mutation, N-terminus histidine-tagged, derived
from pIX-2

pIX-2KtoA

612 bp pIX3.0 containing umuDAb plus a T7 promoter, ribosomal binding site, and T7 This study
terminator with nucleophilic activator mutation, N-terminus histidine-tagged, derived
from pIX-2

w

-..J

This study

Making mutations in UmuDAb

In previous experiments performed by Nohtni et al. (1987), a mutation from
glycine to glutamic acid at the second amino acid residue of the C24 -G25cleavage site
of E. coli UmuD reduced SOS mutagenesis drastically. Similarly, a mutation of the
nucleophilic activator residue lysine to alanine had a severe effect on SOS
mutagenesis. So, mutations were constructed at these locations in UmuDAb, using the
QuickChange™ Site-Directed Mutagenesis System (Stratagene, CA), a common and
widely applicable PCR-based protocol for creating site-directed mutations.
The plasmids pIX-2 or pJHl were PCR amplified with the sense and antisense
primers and other contents as shown in Table 4. The designed primers are
complementary to the opposite strands of the plasmids. These primers are extended
by PfuTurbo DNA Polymerase during the temperature cycling of the procedure. The
aillplified PCR products were restriction digested with Dpnl to get rid of original nonmutagenized parental DNA and were transformed into XL- IO Gold Ultracompetent
cells (Stratagene). The mutagenized plasmids, after purification from XL-10 cells,
were transformed into E. coli wild type (AB1157) and umuD strains (315) and
selected on 100 µg/mL ampicillin media plates.
Primer Design

The primers for the site-directed mutagenesis were designed usmg the
QuickChanage™ Site-Directed Mutagenesis Kit (Stratagene, catalog no. 200518)
instruction manual, which was used to follow the parameters of the sense and
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antisense primers. An automated tool at the Agilent website was used to design the
primers (http://www.genomics.agilent.com). The umuDAb sequence (ACIAD2729)
(Barbe et al., 2004, and www.genoscope.cns.fr/agc/mage/acinetoscope), was used as
a template for designing primers. When designing a primer for mutagenesis purposes,
these characteristics must be strictly followed: I) Both of the forward and reverse
primers must be contain the desired mutation and anneal to the sequences on opposite
strands of the plasmid; 2) Primers should be between the lengths of 25 & 45 bases; 3)
Primers should have a melting temperature (Tm) of::: 78°C, 4) The desired mutation
should be in the middle of the primer with- 10-15 bases of the correct sequence on
both sides; 5) The primers should have a minimum GC content of 40% and preferably
terminate in one or more G or C bases; 6) Primers must be purified by
polyacrylamide

gel

electrophoresis

(PAGE)

or

high-performance

liquid

chromatography (HPLC) (QuickChange™ Site-Directed Mutagenesis Kit).
After their design, primers were constructed and purchased from Integrated
DNA Technologies. The forward and reverse primers fo~ the mutated glycine to
glutamic acid residue in the cleavage site were g181a_tl82gS and g18la_t182gAS
respectively. Similarly, forward and reverse primers K97 ASense and K97 AntiSense
were constructed and purchased for the mutated lysine 156 to alanine nucleophilic
activator residue mutation. The mutation primers used in this study to create sitedirected mutagenesis are listed in Table 3.
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Table 3. PCR primers designed for the site-directed mutagenesis

Name of primer
gl8la_t182gS

Purpose

Sequence

Forward primer for
mutation of glycine to
glutamic acid residue at the
predicted cleavage site

5'-CAGAACGTGTTGCTGCTGAGTTGCCATCACCTGCACAG-3'

gl8la_tl82gAS Reverse primer for
mutation of glycine to
glutamic acid residue at the
predicted cleavage site
K97ASense
Forward primer for
mutation oflysine to
alanine residue at the
nucleophilic activator site
K97 AntiSense
Reverse primer for
mutation of lysine to
alanine residue at the
nucleophilic activator site

5'-CTGTGCAGGTGATGGCAACTCAGCAGCAACACGTTCTG3'

5'-GTTGACAATGAGTTTACGGTAGCCCGTCTGATGATCGATCATC-3'

5'-GATGATCGATCATCAGACGGGCTACCGTAAACTCATTGTCAA-3'

PCR Amplification
The purpose of PCR amplification was to produce large amounts of mutated
DNA products from a small amount of the original, wild type DNA encoding umuD.
The sample reaction was prepared as follows:

Sample Reaction Preparation
The following contents were placed in a thin walled 0.2 mL PCR tube and
amplified in a Veriti™ 96 Well Thermal Cycler (Applied Biosystems, CA).

Table 4. Preparation of sample reaction for PCR cycler
Amount(µL)
5
3.78

Comment

Ingredient
1OX reaction buffer
dsDNA template, 10ng/µL

Either

pIX-2

or

pJHl
10
10
1
20.22
1

Oligonucleotide #1, final
concentration of 125rn,/10 uL
Oligonucleotide #2, final
concentration of 125n!!/10 µL
dNTP mix, 25mM

Forward primer
Reverse primer

ddH2O

PfuTurbo DNA polymerase (25
U/µL)

After the PCR tubes were placed in the PCR thermal cycler, an amplification
reaction was run with the parameters as shown in Table 5.
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Table 5. Cycling parameters for the QuickChangeTM site-directed mutagenesis
method

Segment

Cvcles

Temperature

Time

1

1

95°c

30 seconds

2

16

95°c

30 seconds

5s 0 c

1 minute

68°C

5.5 minutes

Following temperature cycling, the reaction was placed on ice for 2 minutes to
cool the reaction to 2:: 37°C.
10 µL of PCR product was mixed with loading dye and run in a 0. 7% gel.
Lambda DNA cut with HindIII was used as a molecular weight marker. The
remaining PCR product was digested with Dpnl.
Dpnl digestio11 of the a111plijicatio11 products
The purpose of Dpnl digestion is to allow the mutagenized plasmid to be
transformed but not the original parental plasmid. The parental methylated DNA is
digested by Dpnl and the PCR products remain intact because the newly synthesized
DNA is non-methylated. This step ensures us that only the mutagenized plasmid is
transformed. 1 µL of the Dpnl restriction enzyme (10 U/µL) was added directly to
each of the amplification reactions. Each reaction was gently and thoroughly mixed
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by pipetting the solution up and down (6-8 times). The reaction mixtures were spun
down in a microcentrifuge for 1 minute and were incubated at 37°C for 1 hour.

Tra11sformatio11 ofXL-IO Gold Ultracompete11t cells
The XL-10 Gold Ultracompetent cells (QuickChange® XL Site-Directed
Mutagenesis Kit, Stratagene, cat no. 200517-4, lot no. 006047569) are designed for
efficient transformation of large DNA molecules. The XL-10 Gold strains are also
designed to allow cloning of methylated DNA and aids in producing higher quality of
miniprep DNA. The XL-10 Gold Ultracompetent cells stored at -80°C were gently
thawed on ice. 50 µL of the Gold Ultracompetent cells were aliquoted to a prechilled
14-mL BD Falcon polypropylene round-bottom tube (Becton Dickinson, catalog no.
352059) for 30 minutes. 1 µL of the DpnI treated DNA was added to the cells in the
Falcon tube on ice for few minutes. The transformation reaction was heat shocked at
42°C for 45 seconds. The reaction tubes were placed on ice for 2 minutes. 0.5 mL of
SOC media preheated at 42°C SOC media was added to the transformation tubes and
the tubes were incubated at 37°C for 1 hour in a shaking incubator at 225 rpm. After
the 1 hour incubation, 250 µL of the transformation reaction was plated on two
nutrient agar (NA) plates containing ampicillin (100 µg/mL), and 48 µL X-Gal. The
plates were then incubated at 37°C for> 16 hours.
The nutrient agar (NA) plates were checked for the growth of white colonies.
The white colonies were restreaked in nutrient agar plates containing ampicilin ( 100
µg/mL) and incubated overnight at 37°C.
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Plasmid Purijicatio11

The purpose of this step was to purify the pIX-2 plasmids containing the
umuD cleavage and nucleophilic activator residue mutations so that they could be

then transformed into E.coli wild type (AB1157) and umuD (315) competent cells
where the mutated gene would be expressed. The QIAprep® Spin Miniprep Kit
(QIAGEN Sciences, catalog no. 27106) was used to purify the plasmids from the
overnight cultures of the transformed XL-10 Gold Ultracompetent cells. Several
microcentrifuge tubes were filled with 1 mL of double distilled H2O (ddH2O).
Applicator tips were used to acquire colonies from the overnight plate cultures and
colonies were transferred into the microcentrifuge tubes containing sterile water and
resuspended. The tubes were centrifuged for 2 minutes at 14,000 rpm. The
supernatant was discarded. The bacterial pellets were resuspended in 250 µL Buffer
Pl (stored at 4°C) containing 100 µg/mL of RNAse A. 250 µL of Buffer P2 was
added and gently and thoroughly mixed by inverting the tubes 4-6 times. 350 µL of
Buffer N3 was added and immediately mixed thoroughly by inverting the tubes 4-6
times. The solution became cloudy at this point. The tubes were centrifuged for 10
minutes at 13,000 rpm. A white compact pellet was seen in the tubes after
centrifugation. The supernatants from the tubes were applied to QIAprep spin
columns by pipetting and centrifuged for 1 minute. The flow-through was discarded.
0.75 mL of the Buffer PB was added to the QIAprep spin columns and centrifuged for
1 minute. The flow-through was discarded and centrifuged for an additional minute to
get rid of the excess wash buffer in the columns. The QIAprep columns were placed
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in new microcentrifuge tubes and 30-50 µL of EB (Elution Buffer) was added to the
center of the QIAprep column. The tubes were let stand for 1 minute and centrifuged
for I minute at 13,000 rpm. The concentration of the plasmids was measured using a
NanoDrop spectrophotometer (ND-1000, NanoDrop Technologies) and the plasmids
were stored at 4°C.

Co1ifir111atio11 of the 111utatio11s
To confirm the presence of the mutations in plX-2, samples of the plasmids
containing the predicted cleavage and nucleophilic activator residue mutations were
either digested with Ddel restriction enzyme or sent to Alpha Biolaboratory in
Burlingame, California for DNA sequencing. Ddel could confirm the Gly to Glu
predicted cleavage mutation because a restriction site was created as a result of the
mutation, which resulted in additional DNA fragment when the samples were run in
agarose gel.

Tra11sfor111atio11 of co111pete11t wild type a11d umuD E. coli
Transforming the AB II 57 and 315 strains with the purified plasmids
containing the mutated cleavage or nucleophilic activator residues in umuD enables
us to study the expression of the mutated gene products in wild type and umuD E. coli
strains. 200 µL of each frozen CaCh competent ABll57 & 315 cells (made
competent in Hare lab) were transferred to a pre-chilled 14-mL BD Falcon
polypropylene round-bottom tube. I µL of the purified and stored plasmid from the
purification step was added to the two Falcon tubes on ice for 30 minutes. The tubes
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were then transferred to a 42°C water bath for 90 seconds. The tubes were
immediately transferred to an ice bath and the reactions were allowed to chill for 2
minutes. 800 µL of preheated SOC medium was added to the tubes. The tubes were
incubated in a 37°C incubating shaker for 45 minutes at 225 rpm to allow the
bacterial cells to recover and express ampicillin resistance. After incubation, the tubes
were centrifuged for a minute at 15000 xg and all of the liquid was plated on a
nutrient agar (NA) plate containing 100 µg/mL of ampicillin per tube.
Co11jir111atio11 ofplasmid prese11ce i11 cells
Since the plasmids pIX3.0 and pffil contain an ampicillin resistance (ampR)
gene as a selectable marker, only the competent cells that contain the plasmid with
the ampR gene are able to survive in ampicillin-containing medium. ampR functions
by encoding for a protein that makes the cells transformed with the plasmids resistant
to antibiotic ampicillin.
Storage of bacterial cultures
The purpose of this step was to store the transformed bacterial cultures
appropriately so that these cultures can be used in the future. Overnight cultures of
bacterial strains were grown in tubes containing 3 mL of Luria-Bertani (LB) broth
and 3 µL (100 mg/mL) of ampicillin. The following day the culture tubes were
vortexed and 750 µL of the liquid cultures were transferred to appropriately labeled
microcentrifuge tubes. 250 µL of sterile 60% glycerol was mixed into the
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microcentrifuge tubes containing the liquid cultures. The tubes were vortexed briefly
and stored at -80°C.
Collection of E. coli cell Iysates and guantitation of protein

Lysate preparatio11
Crude, total protein cellular lysates were prepared from overnight cultures
grown in 3 mL of LB broth added with ampicillin (100 µg/mL) in a 37°C shaking
incubator. 3 mL of the overnight cultures were 1: 10 diluted in 25 mL of LB plus
ampicillin ( 100 µg/mL) in an Erlenmeyer flask and grown at 37°C with shaking at
200 rpm for an additional 3 hours. After 3 hours, 12.5 mL of the cultures was
transferred to a new each flask and 12.5 µL ofmitomycin C (+MMC) (2 µg/mL) was
added to the new flask. MMC is a potent DNA cross-linker, and induces DNA
damage in our experimental setup. Both cultures were grown for additional necessary
time (minutes to hours). Samples 1.5 mL were then collected in microcentrifuge tubes
from either the "+MMC" or "-MMC" at the following increments: 0 minutes, 15
minutes, 30 minutes, 45 minutes, and 60 minutes. Each sample was spun for 3
minutes at 15,000 rpm. The supernatant was decanted and each pellet was
resuspended in a solution of950 µL Laemmli buffer (63 mM Tris HCI, 10% glycerol,
2% SDS, 0.0025% bromophenol blue, pH 6.8) and 50 µL of 2-mercaptoethanol
(Sigma Chemical Co., lot no. 129 F04061). The samples were stored in the -20°C
freezer and boiled for 5 minutes and placed in ice for 5 minutes before use.
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Protein Qua11titatio11 Assay
To ensure that constant amounts of proteins from the lysates were loaded in
each gel, we performed the RC DC Protein Assay (Bio-Rad). 5 µL of DC Reagent S
was added to each 250 µL of DC Reagent A (Bio-Rad, catalog no. 500-0113)
resulting in a mixture called Reagent A'. Five dilutions of a protein standard, bovine
plasma gamma globulin (Bio-Rad, catalog no. 500-0005, purchased in solution as part
of the Bio-Rad protein quantitation assay kit), were prepared by dilution in Lemmaeli
buffer. The resultant concentration of the protein ranged· from 0.2 mg/mL to 1.5
mg/mL. These diluted proteins were used to prepare a standard curve each time the
assay was performed. 25 µL of standards or lysate sample was placed in a clean
microfuge tube containing 125 µL of Reagent A'. 125 µL of RC Reagent I (Bio-Rad,
catalog no. 500-0117) was added to each tube. The tubes were vortexed briefly and
incubated for I minute at room temperature. 125 µL of RC Reagent II (Bio-Rad,
catalog no. 500-0118) was added to each tul:>e, vortexed briefly, and centrifuged at
15,000 g for 3-5 minutes. The supernatants were discarded and the liquid was allowed
to drain completely from the tubes. 127 µL of Reagent A' was added to each tube and
vortexed. The tubes were incubated at room temperature for 5 minutes or until the
precipitate was completely dissolved. The tubes were vortexed, 1 mL of DC Reagent
B (Bio-Rad, catalog no. 500-0114) was added to each tube and vortexed immediately
again. The tubes were incubated at room temperature for 15 minutes. The
absorbances were recorded at 750 nm with the relative blue color of intensity
correlating with increasing protein. A standard based on the readings from the BSA
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standards was created and the amount of protein m each lysate sample was
determined.

Western Immuno-blot and analysis of proteins

Either a Mini-PROTEAN® TGX™ gel (4-20% Tris-HCI, Bio-Rad) or a
Criterion™ Precast gel (10-20% Tris-HCI, 1.0 mm, BIO-RAD) was run in order to
separate various proteins by size. Frozen lysates were boiled for 5 minutes and put on
ice for 5 minutes each time a PAGE was performed. The amount of protein samples
ranging from 1.75 µg to 12 µg (determined from RC DC Assay) were loaded in the
gel. The amount of protein corresponds to the micrograms (µg) of total protein per
lane. The gel was run for 1 hour at 125 volts for a Mini-PROTEAN® gel or 3 hours at
125 volts for the Criterion™ gel at 4 °C. The gel running buffer was composed of: 25
mM Tris base, 192 mM glycine, and 10% SDS.

After running the gel for an appropriate time, the proteins in the gel were
transferred to an Immun-Blot PVDF membrane (Immun-Blot™ PVDF Membrane,
Bio-Rad, lot no. D103267 for 10 x 15 cm or Immun-Blot™ PVDF Membrane, BioRad, lot no. BR0028003 for 7 x 8.4 cm) using the Trans-Blot apparatus (Bio-Rad,
Criterion™ Blotter). The apparatus was run for I hour at 100 volts at 4°C with
transfer buffer (25 mM Tris base, 192 mM glycine, 10% methanol (Fisher Scientific,
lotno. 107631)).
After the protein was transferred to the membrane, the membrane was air
dried, pre-wetted in 100% methanol and incubated overnight in 0.05% Tween-20
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(Bio-Rad, catalog no. 170-6531) in Tris Buffered Saline (TBS) (25 mM Tris, 137 mM
NaCl, 2.7 mM) containing 5% milk (Blotting grade blocker non-fat dry milk, BioRad, catalog no. 170-6404) on a Belly Dancer (Stovall Life Sciences Inc.) at speed 2
at 4°C. The following day, the membrane was incubated in 0.05% TBS Tween-20
containing 2.5% milk and diluted primary antibody.
Primary antibodies used were either an anti-peptide antibody directed at a 15
amino acid peptide located 79 amino acids upstream of the predicted cleavage site
(Figure 9) or polyclonal antibody. The polyclonal anti-UmuD antibody was prepared
by GenScript Corp., New Jersey, USA. Purified UmuDAb proteins were constructed
by GensScript from the umuDAb sequence and the proteins were injected in rabbits.
The serum containing the anti-UmuD polyclonal antibody were then isolated from the
rabbits. Anti-peptide 2 (peptide specific) or polyclonal anti-UmuD antibodies were
used at a dilution of 1:10,000, and secondary antibody (Goat Anti-Rabbit HRP
Conjugate, Bio-Rad, catalog no. 170-5046) was used at dilution of 1:32,000. All
antibody incubations were carried out separately for 1 hour each. The membrane was
washed five times with 0.01% TBS-Tween 20 for 10 minutes in between the primary
and secondary antibody incubation and after secondary antibody incubation. Precision
StrepTactin-HRP Conjugate (Bio-Rad, catalog no. 161-0380) at a dilution of 1:i0,000
was added with the secondary antibody. The secondary antibody is linked to an
enzyme horseradish peroxidase (HRP) and binds to the primary antibody. The HRP
cleaves a chemiluminescent substrate, resulting in generation of luminescence
proportional to the quantity of protein present in the membrane. Chemiluminescent
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substrate (SuperSignaI® West Pico Chemiluminescent Substrate, Thermo Scientific,
lot no. LC 141629) was prepared for the membrane and was gently pipetted onto with
the PVDF membrane. After incubating in the dark with the substrate for 10 minutes,
the film was sandwiched between transparency papers. The membrane sandwich was
placed into an X-ray film cassette and the orientation was marked. The membrane
was exposed to X-ray film in a medical film processor (Konica Minolta, SRX-101A,
Z & Z Medical, Inc.) for different time exposures and the film was developed with
developer (Med-Dent Developer, White Mountain Imaging, catalog no. 2501-FG) and
fixer (Med-Dent Developer, White Mountain Imaging, catalog no. 2502-FG).

MSOdNKNEHGGARTNAGRKlAK.YQEPTKVIRVPESQVAFIKRWLLDNVKTDN
LIDFNSALKVQAIQPNPTKIYQIPLATERVMGtPSPAQEHVEQSLDLNEYLVR
NENATFIVKANSLSMLDAGIDIDDPLIVDRSITAKAGDIVIAMVDNEFTVKRLI
DHHFHPPKVWLKAENPDFQNIYIDEGQELVIWGVVTYNLKPMR

......

Figure 9. Sequences recognized by anti-peptide antibody. Primary anti-peptide
antibody recognizes the 15 amino acids (shown in box) upstream of the predicted
cleavage site. The dotted box represents the predicted cleavage site ofUmuDAb.
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Results

The main objective of my research was to determine if the UmuDAb protein
was being expressed in wild type and umuD mutants of E. coli, and was self-cleaving
over time after the cells were treated with a DNA damaging agent. In addition, we
also wanted to determine if the mutations in the predicted cleavage or nucleophilic
attack residues blocked or inhibited the disappearance (cleavage) of the protein over
time. Therefore, Western blot analysis was performed and observations made were
compared with E. coli model for similarities and contrasts.
The umuD found in ADPI is about 1.5 times the size of umuD in E. coli and
other bacteria and research has shown that the functioning of the umuDAb encoded
gene product is unlike other bacteria such as E. coli (Hare et al., 2006). Western blot
analyses performed in Hare lab have shown the size of the protein to be
approximately 23 kDa (Experiments in Hare lab and this study). The pJHI plasmid
containing the native promoter expresses the -23 kDa protein. The plX-2 plasmid
containing the constitutive promoter also expresses the protein of-23 kDa.
Table 6 shows features ofUmuD participation in E.coli. My objectives of the
thesis are to address similar processes or features in ADP!. Different approaches have
been taken to investigate these features in ADP I. In E. coli, UmuD self-cleaves in a
reaction mediated by *RecA after DNA damage (Shinagawa et al., 1988; Burckhard!
et al., I 988) and to investigate if UmuDAb self-cleaves in response to DNA damage,
umuDAb will be expressed in umuD strains of E. coli. In order to examine RecA
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involvement in the disappearance (cleavage) of UmuDAb, UmuDAb will be
expressed in DH5a and AB2463 cells that lack recA gene and these cells will be
treated with MMC. The apparent cleavage time scale ofUmuDAb will be calculated
as the half-life after the cells expressing UmuDAb are treated with MMC. To
examine the predicted cleavage site of UmuDAb, the glycine residue at the predicted
cleavage site of the protein at A83 -G84 site will be mutated to glutamic acid. Similarly,
the conserved lysine residue that acts in E. coli as a nucleophilic activator will be
mutated to alanine to observe its effects in the cleavage of the protein.
Table 6. Features of the E.coli involvement ofUmuD in the SOS mutagenesis of
DNA damage response
Processes/Features of
UmuD cleavage
RecA involvement

E.coli

Reference(s)

Requires RecA

Cleavage time scale

-20 min after DNA
damaee
C,.-G,,

Witkin. 1976;
Walker, 1984;
Perry et al., 1985
Shinagawa et al., 1988
Burckhard! et al., 1988
Opperman et al., 1999

Cleaved where?
Amino acids required for
cleavaee
SOS mutagenesis
phenotype required
UmuD involvement

Ser, & Lys

Nohmi et al., 1988
Nohmi et al., 1988

C,.-G,, Cleavage, Ser, &
Lys

Nohmi et al., 1988

UmuD self cleavage

Burkhardt et al., 1988;
Nohmi et al., 1988;
Shinagawa et al., 1988;
Paetzel and Woodgate,
2004
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UmuDAb protein is expressed in E. coli
Wild type cells express UmuDAb, which disappears over time after MMC treatment

Western analysis showed that UmuDAb of ADP! is expressed in the wild type
E. coli strain AB 1157 and the size of the protein is approximately 23 kDa as predicted

by the open reading frame (Hare et al., 2006) (Figure 8). The expression of the
protein disappeared over time in cells treated with 2 µg/mL of MMC, whereas the
levels ofUmuDAb were consistent over time in non-MMC treated cells. The apparent
"disappearance" of UmuDAb (Figure 11, lanes 2 and 3) could be as a result of
cleavage of the protein at the predicted cleavage site in response to MMC-induced
DNA damage because when anti-peptide antibody is used, the larger ~16 kDa
expected cleavage product cannot be expected to be seen or recognized on the
Western blot. This is because primary anti-peptide antibody recognizes the 15 amino
acids (shown in box) upstream of the predicted cleavage site (Figure 9).
A cross-reacting protein of approximately 19 kDa is seen in the Western blot
(Figure 11, lanes 2, 3, 4, 5, 6, and 7; and Figure 12 A and B, lanes 3-18 for both).
Furthermore, AB 1157 cells alone can express the cross-reacting protein (Data not
shown, personal communication with M. Whitaker of Hare lab). The 19 kDa protein
is neither UmuD nor UmuDAb because the molecular weights of UmuD and
UmuDAb are 15.0 (Kitagawa et al., 1985) and 23.0 kDa respectively. The control
cells that contain the vector alone with no umuDAb do not express UmuDAb but the
cross-reacting proteins are still seen (Figure 11, lanes 8 and 9).
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Figure 11. Expression and disappearance or no disappearance ofUmuDAb in wild type, umuD, and recA
strains of E. coli. The cells were treated with MMC for 1 hour. "+" indicates cells treated with 2 µg/mL of MMC,
"-" refers to no MMC treatment. Primary antibody used was anti-peptide 2. Lanes 8 and 9 contain proteins from
wild type with vectors pUC19 and pIX3.0, alone respectively.

E.coli UnmD is 11ot required for UmuDAb disappeara11ce after DNA damage
Western blot analysis indicated that UmuDAb was also expressed in E. coli
cells that completely lack their umuD gene. The size of the expressed protein was
approximately 23 kDa. UmuDAb disappeared over time in MMC unttreated cells in a
time-dependent manner whereas the amounts of the protein were consistent over time
in non-MMC treated cells (Figure 12 A and B). Because the umuD E. coli completely
lack the umuD gene that encodes its own UmuD (Personal communication with P.
Buening), and UmuDAb disappeared over time in MMC treated cells, we conclude
that E. coli UmuD is not required for or involved in UmuDAb disappearance.

UmuDAb disappears i11 both wild type a11d umuD strai11s ofE. coli
In order to examine the phenomenon of disappearance of UmuDAb more
closely with respect to its timing, more short-term protein lysates were collected after
MMC treatment. Figure 12 A and B suggest that UmuDAb is expressed, but
disappears after MMC-induced DNA damage over similar amounts of time in both
wild type and umuD strains of E. coli. UmuDAb was expressed and the protein
disappears over time with MMC treatment. This suggests that MMC acts as a DNA
damaging agent and UmuD is self cleaving, which is consistent with E. coli model.
Other experiments in the Hare lab (Personal communication with S. Wheeler and K.
Lambert of Hare lab) also have shown that UV-C exposure causes disappearance
(apparent cleavage) ofUmuDAb.
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disappears over time in wild type with MMC treatment. "+" indicates cells treated with 2 µg/mL of MMC,
"-" refers to no MMC treatment. Primary antibody used was anti-peptide 2 antibody.
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Timing ofUmuDAb disappearance resembles that ofE. coli

In order to compare the disappearance of UmuDAb in wild type and umuD
strains of E. coli in a more quantitative manner such as to see if the protein cleave
with same timing, ImageJ Software (National Institutes of Health) was used to
determine the percent of UmuDAb remaining after DNA damage. The percent
remaining was calculated at different intervals of times after addition of MMC to the
cultures: 0 minutes, 5 minutes, IO minutes, 15 minutes, 20 minutes, 25 minutes, 30
minutes, 45 minutes, and 60 minutes. The decay ofUmuDAb for all the experiments
was calculated to be -20 minutes, which is similar to - 20 minutes (Opperman et al.,
1999) for E. coli. The timing of disappearance of the protein was determined as a
half-life time from a percent remaining versus time (min) graph for the protein as
shown in Figure 13.
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Figure 13. Half -life of UmuDAb protein. Percentage of UmuDAb remaining over time manner in both MMC
treated and untreated samples of wild type and umuD strains of E. coli expressing UmuDAb. The horizontal and
vertical dotted lines represent the halflife for the disappearance ofUmuDAb in wild type and umuD E. coli.

RecA is required for the cleavage ofUmuDAb
In E. coli, RecA is activated by DNA damage to subsequently bind to UmuD
and facilitate its self-cleavage (Shinagawa et al., 1988; Burckhardt et al., 1988). To
assess the role of RecA in the disappearance of UmuDAb, UmuDAb disappearance
was examined in the DH5a recA strain of E. coli that was used to produce pIX-2.
The wild type and recA strains of E. coli were grown for > 16 hours, then I: IO diluted
and grown for additional 3 hours. The cells were then treated with MMC for I hour.
In wild type and umuD strains, UmuDAb disappears after a I hour treatment with
MMC (Figure 14). In DH5a cells that are mutated in their recA gene, however, the
level of UmuDAb expression was consistent over time and did not disappear. This
suggests that RecA is required for the disappearance ofUmuDAb after DNA damage,
and is consistent with the idea that the "disappearance" is cleavage.
However, the DH5a strain of E. coli contains many additional mutations in its
genotype, relative to AB 1157, in addition to recA, therefore it was necessary that we
use an isogenic strain of wild type AB! 157 that has a mutation in its recA gene only.
AB2463 is an isogenic strain of wild type AB 1157 with a mutation in its recA gene
that encodes for RecA (Horii et al., 1979). To further assess the role of RecA in the
disappearance of UmuDAb after DNA damage, AB2463 cells containing various
plasmids such as pJHI, pIX-2 and pIX-1 were grown as described in Materials and
Methods, and treated with MMC for I hour. The recA+ strain ABI 157 was also
treated with MMC as a control. As shown in Figure 15, UmuDAb does not disappear
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in recA strains after I hour MMC treatment. However, UmuDAb disappears in the

recA+ strains, offering further evidence that RecA is required for the disappearance of
UmuDAb after DNA damage.
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UmuDAb mutant in predicted cleavage site still disappears in time-dependent
manner after MMC treatment

To test whether the observed disappearance ofUmuDAb was really a result of
the cleavage in the predicted cleavage site of the protein, I constructed a mutation in
the predicted cleavage site of the protein at A83 -G84 site. The glycine at the predicted
cleavage site was mutated to glutamic acid because by changing the Gly-25 residue of
the putative Cys-Gly cleavage site to a glutamic or lysine residue in E. coli UmuD
significantly reduced the ability ofUmuD to function in SOS mutagenesis (Nohmi et

al., 1988).
Proteins lysates were prepared from the wild type and umuD E. coli as
described in the Materials and Methods and examined with Western blot analyses
with a polyclonal antibody directed against the entire UmuDAb protein.
Figure 16 shows the effect of the predicted cleavage site Gly-84 to Glu-84
mutation on the disappearance of UmuDAb. Wild type that contained the plasmids
with the predicted Gly-84 to Glu-84 cleavage mutations in umuDAb express the
protein, which similar to the unmutated UmuDAb, almost completely disappears at
60 minutes with MMC treatment (Figure 16, lanes 6 and 7). Similar results were seen
in the umuD strain background: the mutated UmuDAb protein still disappeared after
60 minutes of MMC treatment (Figure 16, lane 9).
This first immunoblot, shown in Figure 16 was performed on sample lysates
collected at O minutes and 60 minutes only. To obtain better observations on the
disappearance of an UmuDAb, immunoblot was re-run with lysates collected on
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different dates at 0 minutes, 30 minutes, 45 minutes, and 60 minutes. Moreover, the
primary antibody used this time was polyclonal antibody that recognizes the entire
UmuDAb unlike peptide-specific antibody that is sequence specific directed at a 15
amino acid peptide located 79 amino acids upstream of the predicted cleavage site
(Figure 9). This is desirable because the polyclonal antibody is directed against the
whole UmuDAb protein and therefore also recognizes the.cleaved UmuD' product.
Figure 17 shows the effect of the predicted cleavage site Gly-84 to Glu-84
mutation on the disappearance ofUmuDAb. The levels ofUmuDAb in either the wild
type or umuD strains were consistent in cells that were not treated with MMC (Figure
17, lanes 2, 4, and 6 or lanes 13 and 15). The un-mutated UmuDAb expressed by the
wild type and umuD strains disappeared over time with MMC treatment (Figure 17,
lanes 2, 3, and 5 or lanes 13, and 14). Wild type cells that contain the plasmids with
the predicted Gly-84 to Glu-84 cleavage mutations in umuDAb express the protein,
which completely disappears at 60 min with MMC treatment (Figure 17, lanes 7, 8,
and 10). Similar results were seen in the umuD strain background: the UmuDAb
cleavage mutants still disappeared after 60 min of MMC treatment.
In contrast to the results seen in Figure 16, with the use of polyclonal
antibodies, we see a -14 kDa cleavage product appearing in only MMC treated cells,
which may correspond to a UmuD' form (Figure 17, lanes 3, 5, 8, 10, and 16). The
larger molecular weight, -16 kDa of cleavage product for cleavage mutants suggests
that UmuDAbG84E might be using an alternate cleavage site. Figure 18 shows the
percentage ofUmuDAb remaining in a time-dependent manner in both MMC treated
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and untreated samples of wild types and cleavage mutants, as determined by the
ImageJ program.

68

kD

250
150
100

11/IIIID"

......

i5

,,

.so

UnmDAb

, Un)uDAbGtoE

60°

3i

0

6o+

60-

UmuDAbGtoE

60+

60~

25
20

~

•

6 -

7

-. 8

9

10

Figure 16. Expression of UmuDAb by wild type and umuD predicted cleavage mutants. "+" indicates cells
treated with 2 µg/mL of MMC, "-" refers to no MMC treatment. The primary antibody used was peptide-specific
anti-peptide 2 antibody.

kD
250
150

100
i5
50
37

25

•I
•-

AB115i(pIX-2)

'§

' ABIJ57(J>lX-2GtoE)

315(pL"'(-2)

315(1>IX-2GtoE)

0

min 0

20

15 1
Lanes 0 .
---i
0

2

3

4

5

6 _ i

8

9

10

11

12

13

14

15

_!6

li

Figure 17. Expression ofUmuDAb by wild type and umuD predicted cleavage mutants."+" indicates cells
treated with 2 µg/mL of MMC,"-" refers to no MMC treatment. The primary antibody used was polyclonal
antibody that recognizes entire UmuDAb.

120 ~ - - - - - - - - - - - - - - - - - - - - 110

_

+----------------------' ,........ _....
' '-. .. _, , ,_

',

70
60

so
40
30

·,.

~-

' ' -,
,.

20
10

0

·,

..

........ ,, .

"'-.

-... .

10

20

... ....

--;.:--+MMC AB! 157(pIX-2GtoE)

-...
.......... ___ -------~~
-.

30

40

-+-+Ml\.fC AB! !57(p!X-2)
---MMC AB! 157(pIX-2GtoE)

'

:c<::
'

-

0

--Mr,rc .-\Bll57(pIX-2)

__

so

60

70

Time(min)

Figure 18. The percentage of UmuDAb remaining in a time-dependent manner in both MMC treated and
untreated samples of wild types and cleavage mutants. The solid lines represent the UmuDAb in samples
untreated with MMC while the dotted lines represent the UmuDAb in samples treated with MMC.

UmuDAb mutant in nucleophilic activator residue fails to undergo cleavage after
treatment with MMC

Because the UmuDAb expressed by the cleavage mutants disappeared
surprisingly after MMC-induced DNA damage (Figure 16 and 17), we speculate that
the protein cleaves in a site rather than the predicted cleavage site or the protein uses
alternate mechanism for the cleavage. Therefore, I constructed a mutation in the
lysine residue (Lys-156) of the UmuDAb that acts as a nucleophilic activator for the
cleavage mediated by serine. The lysine at the nucleophic activator residue was
mutated to alanine because by changing the Lys-97 residue to alanine in E. coli
UmuD drastically reduced the ability of UmuD to function in SOS mutagenesis
(Nohmi et al., 1988).
Proteins lysates were prepared from the wild type and umuD E. coli as
described in the Materials and Methods and examined with Western blot analyses
with a polyclonal antibody directed against the entire UmuDAb protein.
In Figure 19 A and B, we see that UmuDAb is expressed by wild type and
umuD strains of E. coli and disappears in a time-dependent manner in MMC treated

wild type and umuD mutants, disappearing completely at 60 min. This disappearance
is dependent on MMC treatment, as UmuD does not disappear in MMC untreated
cells.
Figure 19 A and B show that UmuDAb that is mutated in its nucleophilic
activator residue (Lys-156 to Ala-156), is also expressed by wild type and umuD
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mutants of E. coli. However, UmuDAb containing the nucleophilic activator residue
mutation does not disappear over time after MMC treatment in either in wild type or
umuD mutants of E. coli. The levels of expression of UmuDAb is consistent over
time in both MMC-treated and untreated samples of wild type and umuD mutants.
This suggests that the "disappearance" is actually cleavage, mediated by a reaction
like that of other peptidases such as LexA and UmuD, which depend on the Lys-Ser
enzymatic dyad (Figure 7).
Figure 20 represents a graph that shows the percentage of UmuDAb
remaining in a time-dependent manner in both MMC treated and untreated samples of
wild type and nucleophilic activator residue mutants whereas Figure 21 represents a
graph that shows the percentage ofUmuDAb remaining in a time-dependent manner
in both MMC treated and untreated samples of umuD mutants and nucleophilic
activator residue mutants. Figure 20 shows that the levels of UmuDAbKtoA is
consistent over time in the wild type nucleophilic activator residue mutants treated
with MMC while the UmuDAb has completely disappeared in wild type cells after
MMC treatment. Similarly, Figure 21 shows that the levels of UmuDAbKtoA is
consistent over time in umuD nucleophilic activator residue mutants after MMC
treatment while the protein has completely disappeared in umuD cells that express
UmuDAb after MMC treatment.
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What we know now of A. baylyi model system

Table 7 contains the summary of results after numerous Western blot analyses
were performed to better understand the role and action of UmuDAb action after
DNA damage response. Most of the processes or features of UmuDAb action after
DNA damage have been addressed while some of the features still need to be
determined, which will be the basis of future experiments.
Table 7. Processes/features observed in E. coli model system and that were
addressed in this study.

Processes/Features

E. coliUmuD

A. baylyi UmuDAb

RecA involvement

Requires RecA

Requires RecA

Cleavage Time Scale

-20 min

-20min

Cleaved where?

C'"-G"

Not the predicted A 00 -G ••

Amino acids required for Ser, & Lys
cleavage
Phenotype required for SOS
C'"-G·' Cleavage
mutagenesis
viaSer&Lys
UmuD involvement
UmuD self cleavage
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Lys is required
Ser-no data
No data
E. coli UmuD is not
required, suggests UmuDAb
cleavage

Discussion

Various endogenous or exogenous factors can damage DNA, and in order to
sense and repair these damages, cells have developed a variety of DNA damage repair
mechanisms. As already mentioned above, there are two main ways by which cells
can sense and repair damages: error-free repair and error-prone repair mechanisms. A
cell's repair machinery is always on lookout attempting to fix these DNA damages
and a cell may have the following three fates as a result of this attempt to deal with
DNA damages: 1) the damaged DNA is repaired perfectly by error-free DNA repair;
2) the cell may undergo programmed cell death or apoptosis if the damage cannot be
fixed or if the repair is partial; and 3) the cell may carry out error-prone repair with
elevated levels of mutation loads in DNA.
When the levels of DNA damage is so extensive that error-free DNA repair,
such as BER, NER, and _recombinational DNA repair (Friedberg et al., 2006) cannot
repair the damage, DNA replication is stalled. This triggers the mutagenic phase of
the SOS response (Walker, 1984; Echols and Goodman, 1990), also known as SOS
mutagenesis that leads to translesion synthesis (TLS) (Bridges and Woodgate, 1985;
Goodman, 2002).
After DNA damage, single-stranded DNA generated by a halt in replication
converts a key regulatory protein RecA to its activated form (RecA *), which
facilitates the autocleavage of LexA repressor and induces several SOS genes such as

umuD, umuC, polB, recN, su/A, uvrB, and uvrD to be expressed (Friedberg et al.,
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1995). LexA represses the expression of umuD and umuC genes by binding to a "SOS
box" (Mount et al., 1972). RecA * also facilitates the self-cleavage of UmuD to its
cleaved form UmuD', which can complex with UmuC to form the error-prone DNA
polymerase V (Tang et al., 1999) that carries out SOS mutagenesis. UmuD2C
complex acts as checkpoint inhibitor of cell division by slowing down the cell cycle
and allowing more time for error-free mechanism to act (Opperman et al., 1999).
UmuD protein may play a role in shutting off SOS response by binding with UmuD'
and forming a heterodimer UmuDD'C complex (Battista et al., 1990).
The umuDAb gene found in ADPl has an extra N-terminus region unlike E.
coli. However, bacteria such as Synechococcus elongatus, Legionella penumophila
strain Lens and Chromobacterium violaceum have "extra-long" UmuD similar to
ADPl (Figure 8). The umuDAb gene of ADP! is 612 bp long and encodes a protein
of 203 amino acids, while umuD gene found in E. coli encodes 140 amino acids
(Figure 5). The umuDAb is about 1.5 times the size of umuD in E. coli (Hare et al.,
2006). In E. coli, UmuD self-cleaves in a reaction mediated by *RecA after DNA
damage (Shinagawa et al., 1988; Burckhardt et al., 1988) to carry out SOS
mutagenesis. In this research, we were interested in investigating if UmuDAb also
self-cleaves similar to E. coli UmuD in response to DNA damage.
Multiple sequence alignment ofUmuDAb and UmuD homologs in E. coli and
other bacteria show that many amino acids required for RecA mediated UmuD selfcleavage in E. coli are conserved in UmuDAb (Figure 8). For example, the cysteine24/glycine-25 cleavage site, serine-60 that carries out the nucleophilic attack at the
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UmuD cleavage site, and lysine-97 that acts as a nucleophilic activator are all
conserved in UmuDAb. However, the multiple sequence alignment suggests that
alanine-83/glycine-84 is the putative cleavage site in UmuDAb. We have thus created
different types of mutations in either the predicted cleavage site or the residues that
are required for effective cleavage in UmuDAb. The Gly-84 at the predicted cleavage
site was mutated to Glu-84, while the Lys-156 that acts as a nucleophilic activator in
UmuDAb cleavage was mutated to Ala-156. The mutated umuDAb genes were then
transformed into E. coli wild type (ABl 157) and umuD (315) competent cells so that
the mutated gene would be expressed and the functions ofUmuDAb could be studied.
Western blot analyses in our lab have shown that UmuDAb is expressed in
both wild type and umuD strains of E. coli. The size of the protein is -23 kDa as
predicted by the open reading frame (Hare et al., 2006). The expression of the protein
disappeared over time in both wild type and umuD strains of E. coli after MMC
treatment (Figure 12 A and B). We have proposed that the apparent "disappearance"
of UmuDAb was as a result of cleavage of the protein at the predicted alanine83/glycine-84 cleavage site in response to MMC-induced DNA damage.
UmuD of E. coli self-cleaves post-trancriptionally in a reaction mediated by
RecA to form UmuD'. A homodimer of UmuD' then complexes with a monomer of
_UmuC (Woodgate et al., 1989) to form a (UmuD')2C complex, an error-prone DNA
polymerase V (Tang et al., 1999), which can conduct SOS mutagenesis in E. coli.
Similarly, Western blot analyses have suggested that E. coli UmuD is not required for
UmuDAb disappearance in response to MMC-induced DNA damage in umuD (315)
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strains of E. coli. 315 strains of E. coli completely lack the umuD gene that encodes
its own UmuD (Personal communication with P. Buening). Since the UmuDAb is
expressed in umuD strains and disappears over time after MMC treatment (Figure
12B, we conclude that UmuDAb is self-cleaving in response to DNA damage or at
least E. coli UmuD is not required for UmuDAb cleavage.
The timing of disappearance of UmuDAb was calculated to be -20 min
(Figure 13). The disappearance timing was similar to that of E. coli UmuD, where
after UV irradiation, uncleaved UmuD accumulates over UmuD' for 20 min. After 20
minutes, UmuD' have been shown to accumulate while uncleaved UmuD slowly
disappears (Opperman et al., 1999). Experiments in the Hare lab (Personal
communication with S.. Wheeler and K. Lambert) also have suggested that UV-C
exposure also causes apparent cleavage of UmuDAb in a way similar to the
disappearance of UmuDAb in response to MMC-induced DNA damage. However,
the timing of the disappearance of UmuDAb in response to UV-C-induced DNA
damage has yet to be determined.
RecA is activated by DNA damage in E. coli in response to DNA damage,
which then binds to UmuD and mediates its self-cleavage (Shinagawa et al., 1988;
Burckhard! et al., 1988). Similarly, our data clearly indicate that RecA is required for
the cleavage of UmuDAb (Figure 14 and 15). UmuDAb is expressed by cells
containing the native and constitutive promoter (Figure 14). UmuDAb disappears in

recA+ (Figure 14, lanes 4 and 5; lanes 6 and 7) after MMC treatment of the cells for I
hour. However, in recA· strains of E. coli (Figure 14, lanes 2 and 3; lanes 8 and 9;
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lanes 10 and 11 ), the levels of UmuDAb is consistent after MMC treatment for I
hour. Moreover, Western blot performed on AB2463, an isogenic strain of wild type
ABl 157 that has recA mutation only, clearly suggested that RecA is required for the
cleavage ofUmuDAb (Figure 15). UmuDAb does not disappear in recA- strains of E.

coli after MMC treatment (Figure 15, lanes 6 and 7; lanes 9 and 10; lanes 12 and 13),
while UmuDAb disappears in recA+ strains of E. coli. This suggests that RecA is
required for cleavage of UmuDAb after MMC-induced DNA damage similar to the
cleavage •Of UmuD in E. coli after DNA damage.
The experiments ofNohmi et al., 1988 suggested that when the Gly-25 at the
predicted cleavage site ofUmuD in E. coli to Glu-25, UmuD's ability to function in
SOS mutagenesis was significantly reduced since the cleavage of the protein was
tremendously blocked. In contrast, the mutation of Gly-84 residue in the predicted
cleavage site of UmuDAb to Glu-84 did not reduce or block the cleavage of
UmuDAb (Figure 16 and 17). The protein mutated at the predicted cleavage site still
disappeared after wild type and umuD strains of E. coli after MMC treatment.
Therefore, we speculate that the mutation does not affect the protein in its cleavage.
Interestingly, a protein of ~16 kDa protein (Figure 17, lanes 8, 10, and 16) is also
recognized by the polyclonal antibody that suggests that the· .protein may have found
an alternate site for the cleavage.
Nohmi et al., 1988 observed that when the nucleophilic activator residue, Lys97 was mutated to Ala-97, there was a substantial reduction in the amount of UV
mutagenesis. The lysine residue is essential for the effective cleavage of UmuD in a
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reaction mediated by a nucleophilic serine residue. Similarly, our data indicate that
UmuDAb protein that has a mutation in its Lys-156 residue fails to undergo cleavage
after MMC-induced DNA damage (Figure 19 A and B). This strongly suggests that
lysine is a key amino acid essential in the effective cleavage of UmuDAb protein
similar to that of E. coli VmuD.
Table 7 summarizes the studies that were done as part of my research project.
The data supports the hypothesis that UmuDAb self-cleaves in response to DNA
damage as E. coli UmuD. Moreover, RecA is also required for the cleavage of
UmuDAb as in E. coli. Furthermore, the data strongly suggest that Lys-156 is
essential for the effective cleavage of UmuDAb in a mechanism similar to that of
Lys-97 in E. coli UmuD.
Future directions may involve studies with creating mutations in the alanine
residue of the predicted cleavage site and serine residue that carries out the
nucleophilic attack in the cleavage site. The mutated UmuDAb will be expressed in
wild type and umuD strains of E. coli and the effect of these mutations on the
cleavage of the protein will be studied.
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